Specially, PD-L1 expression on platelets could not only reflect that on tumor, but also inhibit CD4+ and CD8+ T cells, which provided a new perspective to overcome the limitations of traditional quantification of PD-L1 expression on tumor cells (34). This evidence concerns the gene CD4 and neoplasm.